» Articles » PMID: 21076407

A De Novo Paradigm for Mental Retardation

Abstract

The per-generation mutation rate in humans is high. De novo mutations may compensate for allele loss due to severely reduced fecundity in common neurodevelopmental and psychiatric diseases, explaining a major paradox in evolutionary genetic theory. Here we used a family based exome sequencing approach to test this de novo mutation hypothesis in ten individuals with unexplained mental retardation. We identified and validated unique non-synonymous de novo mutations in nine genes. Six of these, identified in six different individuals, are likely to be pathogenic based on gene function, evolutionary conservation and mutation impact. Our findings provide strong experimental support for a de novo paradigm for mental retardation. Together with de novo copy number variation, de novo point mutations of large effect could explain the majority of all mental retardation cases in the population.

Citing Articles

YY1 mutations disrupt corticogenesis through a cell type specific rewiring of cell-autonomous and non-cell-autonomous transcriptional programs.

Pereira M, Finazzi V, Rizzuti L, Aprile D, Aiello V, Mollica L Mol Psychiatry. 2025; .

PMID: 39987231 DOI: 10.1038/s41380-025-02929-x.


Novel De Novo Intronic Variant of SYNGAP1 Associated With the Neurodevelopmental Disorders.

Xie W, Liao B, Shuai M, Liu R, Hong M, He S Mol Genet Genomic Med. 2025; 13(2):e70066.

PMID: 39878419 PMC: 11775916. DOI: 10.1002/mgg3.70066.


eNSMBL-PASD: Spearheading early autism spectrum disorder detection through advanced genomic computational frameworks utilizing ensemble learning models.

Karim A, Alromema N, Malebary S, Binzagr F, Ahmed A, Khan Y Digit Health. 2025; 11:20552076241313407.

PMID: 39872002 PMC: 11770729. DOI: 10.1177/20552076241313407.


CIC-Related Neurodevelopmental Disorder: A Review of the Literature and an Expansion of Genotype and Phenotype.

Ruiz I, Wiltrout K, Stredny C, Mahida S Genes (Basel). 2024; 15(11).

PMID: 39596625 PMC: 11594087. DOI: 10.3390/genes15111425.


Exploring unsolved cases of lissencephaly spectrum: integrating exome and genome sequencing for higher diagnostic yield.

Furukawa S, Kato M, Ishiyama A, Kumada T, Yoshida T, Takeshita E J Hum Genet. 2024; 69(12):629-637.

PMID: 39123069 DOI: 10.1038/s10038-024-01283-0.


References
1.
Forlani G, Giarda E, Ala U, Di Cunto F, Salani M, Tupler R . The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis. Hum Mol Genet. 2010; 19(16):3114-23. PMC: 2908467. DOI: 10.1093/hmg/ddq214. View

2.
Ng S, Turner E, Robertson P, Flygare S, Bigham A, Lee C . Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 2009; 461(7261):272-6. PMC: 2844771. DOI: 10.1038/nature08250. View

3.
de Vries B, Pfundt R, Leisink M, Koolen D, Vissers L, Janssen I . Diagnostic genome profiling in mental retardation. Am J Hum Genet. 2005; 77(4):606-16. PMC: 1275609. DOI: 10.1086/491719. View

4.
Cook Jr E, Scherer S . Copy-number variations associated with neuropsychiatric conditions. Nature. 2008; 455(7215):919-23. DOI: 10.1038/nature07458. View

5.
Hahm K, Sum E, Fujiwara Y, Lindeman G, Visvader J, Orkin S . Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1. Mol Cell Biol. 2004; 24(5):2074-82. PMC: 350571. DOI: 10.1128/MCB.24.5.2074-2082.2004. View